Cholera affecting refugees in Eastern Congo, MSF reports

"The first case of cholera has emerged among thousands of people in an impromptu refugee camp in eastern Congo who fled fighting between a new rebel group and government forces backed by U.N. peacekeepers," according to Medecins Sans Frontieres (MSF), the Associated Press/Washington Post reports (Muhumuza, 8/3). The first case was detected on Friday, and since then at least nine people have died of the disease, MSF said, according to Al Jazeera (8/5).

Patrick Wieland of MSF "said humanitarian agencies are delivering water to the camp but people probably are collecting the water with dirty containers," and he added there are not enough toilets for the 10,000 to 20,000 people who fled violence in the northern towns of Rutshuru and Kiwanja, the AP notes. "Valerie Amos, the U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, is scheduled to visit Congo and Rwanda [this] week to 'draw attention to the deteriorating humanitarian situation,' the U.N. said Friday," according to the AP (8/3).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains